rs10812428
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10812428
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10937275
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10937275
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs1497546
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs1497546
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
|
30661239 |
2019 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs2523822
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs2523822
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs3129900
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.
|
20639878 |
2010 |
rs3129900
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.
|
20639878 |
2010 |
rs6582630
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs6582630
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs9274407
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs9274407
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs10404821
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs11012476
|
|
Chemical and Drug Induced Liver Injury
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.
|
28388302 |
2017 |
rs112655218
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs113206698
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs114577328
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs114811931
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs115266745
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs116561224
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |